ClinicalTrials.gg
CompletedNCT05196464Updated Apr 22, 2024

ACT Workshops: A Novel Delivery Modality to Increase Access to Care for Rural Veterans

An interventional study of Acceptance and Commitment Therapy (ACT) Workshop and Treatment as usual (TAU) in Access to Care and Psychological Distress, sponsored by Syracuse VA Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-22.

Sponsored by Syracuse VA Medical Center · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Apr 2021, registered Dec 2021).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
37
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study investigates access, effectiveness, and acceptability of 1-day ACT workshops on problematic mental health symptoms.

Read the detailed description

This study proposes to investigate access, effectiveness, and acceptability of 1-day ACT workshops delivered in 2 rural VA primary clinics with 32 Veterans with problematic mental health symptoms (i.e., depression, PTSD, or anxiety) that are risk factors for suicide.

02

Conditions studied

  • Access to Care
  • Psychological Distress
03

In context

Lead sponsor

Syracuse VA Medical Center is the lead sponsor of 11 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    1. current mental health symptoms as measured by one of the following indicators: PHQ-9 ≥ 10, PCL-5 ≥ 30, or GAD-7 ≥ 10.

Exclusion criteria

Exclusion Criteria:

  1. cognitive impairment measured by BOMC,
  2. current psychosis or mania as evidenced in the medical record,
  3. current suicidal intent as measured by the P4,
  4. use of mental health services within or outside of VA in the last 6 months as measured by CPRS and the non-VA services questionnaire.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
37 participants (actual)

Study arms

  • Other
    VA primary care patients

    VA primary care patients with psychological distress are being enrolled

    Behavioral: Acceptance and Commitment Therapy (ACT) Workshop · Behavioral: Treatment as usual (TAU)

Interventions

  • BehavioralAcceptance and Commitment Therapy (ACT) Workshop

    ACT workshops are single-day workshops that last 5-6 hours. The workshops will 1) Acceptance and Mindfulness Training emphasizing new ways of managing troubling thoughts, feelings, and physical sensations (e.g., learning how to recognize, and develop cognitive distance from unhelpful thoughts) and strategies to willingly face experiences that cannot be changed; and 2) Committed Action Training to help Veterans clarify what matters most to them (e.g., valued domains including family, friends, spirituality, career) and what they want to stand for in life, how they want to behave, and what strengths and qualities they want to develop. Within this context, the workshop will encourage engagement in, rather than avoidance of, actions consistent with valued directions, including engagement in healthcare. Workshop participants will be given homework related to implementing a key coping skill.

  • BehavioralTreatment as usual (TAU)

    TAU will consist of a consult to a mental health provider at their rural clinic. The patient will then be scheduled for an intake and offered traditional mental health treatment options. Treatment options are likely to include outpatient individual psychotherapy, psychotherapy groups, or medication management.

06

What researchers measure

Primary outcomes

  1. Access to mental health care

    Access to care is measured by hours of active treatment Veterans receive within and outside of VA.

    Time frame: 1 month

  2. Psychological Distress

    Psychological distress as measured by the Depression, Anxiety, and Stress Scale (DASS-21). Score range on 0-42. Higher scores indicate greater psychological distress.

    Time frame: 1 month

07

Study locations

1 site
  • Syracuse Veterans Affairs Medical Center
    Syracuse, New York 13210, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2021 to primary completion in Jun 2023, 26 months.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 14, 2021
First posted
Jan 19, 2022
StartActual
Apr 1, 2021
Primary completionActual
Jun 30, 2023
CompletionActual
Jun 30, 2023
Last update
Apr 22, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05196464
Lead sponsor
Syracuse VA Medical Center
Collaborators
VA Office of Research and Development, Michael E. DeBakey VA Medical Center
Responsible party
Sponsor
First posted
Jan 19, 2022
Start date
Apr 1, 2021
Primary completion
Jun 30, 2023
Completion
Jun 30, 2023
Last update
Apr 22, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion